Skip to content

Author

Linde L. Jacobs

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Aug 2026

Ensuring access to Tau-Targeting therapies for MAPT frontotemporal dementia: patient community priorities for regulators and industry

This document outlines seven key requests that Cure MAPT FTD made on May 23, 2025 in a Patient Listening Session to the U.S. Food and Drug Administration regarding clinical trial design and the approval of tau-targeting therapies for MAPT FTD patients.

Linde L. Jacobs, T. Steel, Barbara Dawson et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.